Literature DB >> 16385337

Intracranial pressure monitoring and lumbar puncture after endoscopic third ventriculostomy in children.

Giuseppe Cinalli1, Pietro Spennato, Claudio Ruggiero, Ferdinando Aliberti, Michel Zerah, Vincenzo Trischitta, Emilio Cianciulli, Giuseppe Maggi.   

Abstract

OBJECTIVE: The aim of this study is to analyze changes in intracranial pressure (ICP) after endoscopic third ventriculostomy (ETV) performed in children affected by noncommunicating hydrocephalus.
METHODS: ICP was continuously recorded for an average of 7 days in 64 children who underwent 68 ETVs for obstructive triventricular hydrocephalus of various etiology. In the first group (44 children), ETV was performed as the primary treatment; in the second group (20 children), the patients presented with shunt malfunction and underwent ETV and shunt removal. Three of the patients in the second group were reoperated for obstruction of the stoma: two were reoperated once and one was reoperated twice.
RESULTS: ICP changes after ETV were not homogeneous and varied according to etiology: the highest values were observed in patients affected by posterior fossa tumors and the lowest values were seen in patients operated on during shunt malfunction and who had their shunt removed. After 31 procedures (45.6%), ICP remained normal (< 20 mmHg) for the entire duration of the monitoring. After 37 procedures (54.5%), ICP was persistently high on Day 1 (mean, 29.7) and decreased very slowly in the subsequent days, remaining high for 2-9 days (mean, 4.5). After 20 of the 37 procedures with high postoperative ICP, patients presented symptoms of intracranial hypertension that resolved, in most of the cases, with one or two lumbar punctures. Lumbar puncture was noted to be effective in bringing about fast normalization of the ICP and resolution of the symptoms. In 13 patients (19.1%), ETV failed and a ventriculoperitoneal shunt was implanted. After four procedures, the stoma obstructed and the patients were treated, reopening the stoma. Postoperative ICP was not statistically significant higher in the patients in whom ETV failed.
CONCLUSION: The high ICP observed in a group of patients in the early postoperative days is probably related to the slow permeation of the subarachnoid spaces by the cerebrospinal fluid flowing out of the third ventriculostomy. Management of intracranial hypertension after ETV remains a matter of controversy. The role of the lumbar puncture in the faster normalization of the ICP is examined in this article. By increasing the compliance and the buffering capacities of the spinal subarachnoid spaces, it probably decreases the cerebrospinal fluid outflow resistance from the ventricular system, facilitating the decrease of the ventricular volume and allowing faster permeation of the intracranial subarachnoid spaces. High postoperative ICP can account for persistent symptoms of intracranial hypertension and ventricular dilatation on computed tomographic scans after third ventriculostomy. A cycle of one to three lumbar punctures should always be performed in patients who remain symptomatic and who show increasing ventricular dilatation after ETV, before ETV is assumed to have failed and an extracranial cerebrospinal fluid shunt is implanted.

Entities:  

Mesh:

Year:  2006        PMID: 16385337     DOI: 10.1227/01.neu.0000195972.48670.86

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

1.  Ventricular anatomy of hydrocephalus associated with myeloschisis and endoscopic third ventriculostomy.

Authors:  Hiroshi Mori; Shizuo Oi; Yuichiro Nonaka; Ryo Tamogami; Ai Muroi
Journal:  Childs Nerv Syst       Date:  2008-01-11       Impact factor: 1.475

2.  An operative technique combining endoscopic third ventriculostomy and long-term ICP monitoring.

Authors:  Sebastian Antes; Christoph A Tschan; Joachim M Oertel
Journal:  Childs Nerv Syst       Date:  2013-08-29       Impact factor: 1.475

3.  Endoscopic third ventriculostomy in previously shunted children: a retrospective study.

Authors:  Elisabetta Marton; Alberto Feletti; Luca Basaldella; Pierluigi Longatti
Journal:  Childs Nerv Syst       Date:  2010-03-30       Impact factor: 1.475

4.  Shunt independence in paediatric hydrocephalus: our 16-year experience and review.

Authors:  Sara Iglesias; Bienvenido Ros; Guillermo Ibáñez; Andrea Delgado; Ángela Ros; Miguel Ángel Arráez
Journal:  Childs Nerv Syst       Date:  2019-06-27       Impact factor: 1.475

5.  The 'mushroom': a simple and safe technique to avoid cerebrospinal fluid leak after endoscopic third ventriculostomy.

Authors:  W B Lo; F T Afshari; D Rodrigues; A V Kulkarni
Journal:  Ann R Coll Surg Engl       Date:  2020-01-22       Impact factor: 1.891

6.  Shall we treat hydrocephalus associated to brain stem glioma in children?

Authors:  Thomas Roujeau; Federico Di Rocco; Christelle Dufour; Franck Bourdeaut; Stephanie Puget; Christian Sainte Rose; Michel Zerah
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

7.  Continuous spinal drain following endoscopic third ventriculostomy: a proposal to change the definition of failure.

Authors:  Pinar Ozisik; Jonathan Roth; Liana Beni-Adani; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2011-08-21       Impact factor: 1.475

8.  Change in optic nerve sheath diameter as a radiological marker of outcome from endoscopic third ventriculostomy in children.

Authors:  Llewellyn C Padayachy; Tracy Kilborn; Henri Carrara; Anthony A Figaji; Graham A Fieggen
Journal:  Childs Nerv Syst       Date:  2015-03-04       Impact factor: 1.475

9.  Endoscopic third ventriculostomy: can we predict success during surgery?

Authors:  L Romero; B Ros; G Ibáñez; F Ríus; L González; Ma Arráez
Journal:  Neurosurg Rev       Date:  2013-08-30       Impact factor: 3.042

10.  Complex hydrocephalus (combination of communicating and obstructive type): an important cause of failed endoscopic third ventriculostomy.

Authors:  Yad Ram Yadav; Gaurav Mukerji; Vijay Parihar; Mallika Sinha; Sanjay Pandey
Journal:  BMC Res Notes       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.